Skip to main content
. 2012 Jan 9;7:151–162. doi: 10.2147/IJN.S27639

Table 6.

Cytotoxicities of various curcumin to Hela and HT-29 cells

Treatment group (Hela) IC50 (μM)a Treatment group (HT-29) IC50 (μM)a
CUR-FSMEDDS 18.27 ± 1.13 CUR-FSMEDDS 20.57 ± 0.78
CUR-FSMEDDS + 1 mM folate 27.27 ± 1.56 CUR-FSMEDDS + 1 mM folate 30.31 ± 2.71
CUR-SMEDDS 36.69 ± 1.04 CUR-SMEDDS 38.59 ± 0.17
Free curcumin 30.4 ± 1.71 Free CUR 25.62 ± 2.23
a

Note: Data presented as mean value ± standard error, n = 3.

Abbreviations: CUR-FSMEDDS, curcumin-loaded folate-modified self-microemulsifying drug delivery system; CUR-SMEDDS, curcumin-loaded self-microemulsifying drug delivery system; IC50, 50% cell killing; Hela cells, human uterine cervix cancer cell line; HT-29 cells, human colon carcinoma cell line.